https://www.eventscribe.com/2020/painweek/images/painweek-favicon.ico Full Schedule Skip to main content
PAINWeek 2021 Main banner
Icon Legend
This session is not in your agenda.
This session is in your agenda. Click to remove it
  1. Home
  2. Full Schedule
Sort by Full Schedule      Sort by Title      Sort by Track      Sort by Faculty  

Full Schedule

Full Schedule

  • Cancelled
  • 60-Day PNS Treatment May Improve Identification of False-positive and False-negative Responders
  • A Digital Platform to Enable Longitudinal Remote Patient Monitoring Confers a Reduction in Medication Utilization
  • A Long-term Assessment of the Safety, Tolerability, and Durability of an Office-based, Pharmacist-directed Approach to Treatment with Medical Cannabis for Chronic Pain
  • A Needle in a Haystack: OTC Analgesics in Our Opioid Crisis
  • A NEW WEARABLE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICE (ACTITENS®) IS MORE EFFICIENT AND BETTER TOLERATED THAN WEAK OPIOIDS IN THE TREATMENT OF KNEE OSTEOARTHRITIS PAIN. RESULTS OF A RANDOMIZED, CONTROLLED, NON-INFERIORITY TRIAL.
  • A THC/CBD oro-buccal spray with improved mucosal absorption and preliminary efficacy for chronic pain.
  • Abuse and misuse of XTAMPZA® ER relative to other opioid analgesics
  • Abuse of tapentadol compared to other atypical opioids among individuals entering treatment for opioid use disorders
  • ALTO-ED: Initiation of a Multidisciplinary SAMSHA Grant Funded Opioid Use Reduction Program in Two Public Health System Emergency Departments
  • Analgesic Combinations in Fixed and Loose Dose
  • Analgesic efficacy and safety of naproxen sodium versus hydrocodone/acetaminophen in acute postsurgical dental pain: a randomized, double-blind, placebo-controlled trial
  • Approved OIC Medication Use in Emergency Department Patients With Opioid-Induced Constipation
  • Assessing Provider Ratings of Satisfaction and Usefulness of the VEGA HCP report – virtual visit
  • At-Home Virtual Reality Program for Chronic Low Back Pain: Double-Blind, Randomized, Placebo-Controlled Trial
  • Atogepant 60 mg Once-Daily Shows Efficacy for the Preventive Treatment of Migraine: Results From a 52-Week Open-Label Extension Trial
  • Atypical chest pain in Carpal Tunnel Syndrome: A Case Report
  • Buprenorphine Buccal Film Versus Oral Oxycodone: Effects on Pupillometry and Respiratory Depression in a Phase 1 Placebo-Controlled Trial
  • Buprenorphine Buccal Film Versus Oral Oxycodone: Secondary Respiratory, Pharmacokinetic, and Pupillometry Outcomes From a Phase 1 Placebo-Controlled Trial
  • CBD for the Treatment of Pain, Sleep, and Anxiety: An Interim Analysis of the SELECT Study
  • Characteristics of Patients Significantly Impacted by Migraine Presenting in Primary Care but Not for Migraine: Results of the OVERCOME (US) Study
  • COmbining UbRogepAnt and preventives for miGrainE (COURAGE) study using the Migraine Buddy application: A novel, entirely remote design for collecting real-world evidence
  • Comparison of treatment impact of high concentration capsaicin topical system (QUTENZA®) and oral pregabalin on patient reported outcomes.
  • Complex Dependency in High-Risk Cancer Patients
  • Cryoneurolysis via a Deep Genicular Approach to Reduce Chronic Knee Pain in Osteoarthritis: A Case Series
  • Daily Atogepant for the Preventive Treatment of Migraine Increases Responder Rates for Reduction in Mean Monthly Migraine Days
  • Diagnosis and treatment satisfaction of common pain in urban China: a population-based cross-sectional National Health and Wellness Survey
  • Diversion and street price of XTAMPZA® ER relative to other prescription opioids
  • Economic burden of chronic pain in China
  • Effects of Tolperisone on Driving Performance, Drowsiness, and Cognitive Function: Comparison With Cyclobenzaprine and Placebo in a Phase 1, Randomized, 4-Period, Crossover Study
  • Efficacy of a Mind-Body Intervention on Post-High Intensity Exercise Pain in Patients with Fibromyalgia
  • Enkephalin as a Potential Analgesic and CNS Modulator
  • Evaluating the Impact of Interprofessional Teams to Decrease Opioid Risk in a Veteran Population
  • Evaluation of the impact of oral naloxone for opioid induced constipation on opioid demand and analgesia in trauma surgery patients
  • Exploratory Efficacy of INP104 by Migraine Attack Severity and Time of Dosing: Results From the Phase 3 STOP 301 Study
  • FAMILY BURDEN ASSOCIATED WITH PRESCRIPTION NSAID AND OPIOID TREATMENT IN PATIENTS WITH OSTEOARTHRITIS
  • How to improve pain scores and quality of life in chronic pain patients
  • Impact of Limiting Short-Acting Opioids on Chronic Pain Management in Veterans at VA Loma Linda
  • Improvements in Disability and the Interictal Period with INP104: Results from the Phase 3 STOP 301 Study
  • Is There a Role for Transdermal Buprenorphine to Manage Acute Pain in the Clinical Setting?
  • L-Methylfolate as an Adjunctive Therapy in Diabetic Peripheral Neuropathy
  • Long COVID and Challenges to the Post-Pandemic World
  • Long-term Safety and Tolerability of Atogepant 60 mg Following Once Daily Dosing Over 1 Year for the Preventive Treatment of Migraine
  • Machine Learning Algorithms in Prediction of the Patient Classification with Moderate-to-Severe Osteoarthritis of the Hip and/or Knee and Inadequate/Intolerable Response to Multiple Pain Medications
  • Managing Severe Pain of Hospice Patients on Admission
  • MAT outcomes during COVID19 at rural clinics
  • Medical Cannabis as Adjunctive Treatment for Chronic Non-cancer Pain (CNCP) to Reduce High Opioid Doses & Optimize Pain Control
  • Meloxicam IV for the Management of Pain Following Radiofrequency Ablation (RFA) of the Spine: A Case Study
  • Mental Health Predictors of Response to Standard Medical Treatment in an Active Duty Military Pain Specialty Clinic
  • Naloxegol Provided Rapid and Sustained Improvement of Opioid-Induced Constipation (OIC) Symptoms in Older Adults Age ≥ 65 Yrs: A Pooled Analysis of Two Phase 3 Studies
  • Naloxegol Provided Rapid Onset of Time to First Spontaneous Bowel Movement (SBM), Complete SBM and Predictable Efficacy in Older Adults (Age ≥ 65 Yrs): A Pooled Analysis of Two Phase 3 Studies
  • Naloxegol Provides Rapid and Sustained Improvement of Opioid-Induced Constipation (OIC) Symptoms Irrespective of Opioid Dose: A Pooled Analysis of Two Phase 3 Studies
  • Non-Medical Use and Diversion of XTAMPZA ER in the General Population
  • Novel approach for sacral root stimulation as a treatment for chronic pelvic pain in females
  • Opioid Prescribing Patterns in an Emergency Department at a Veterans Affairs Hospital
  • Opioid Stewardship Really WoRx: Leveraging the Electronic Health Record to Support Safe and Appropriate Opioid Use
  • Pain Catastrophizing in Individuals with Poly-trauma and Chronic Pain: Contribution to Activity Limitations
  • Pain Management Documentation Review of a Long-Term Care Facility
  • Painful diabetic peripheral neuropathy: the impact on the patient
  • Patient Acceptability of INP104 Aligns With the Unmet Needs Identified in the I-BEAM Survey
  • Patient clinical characteristics and treatment utilization among patients with migraine initiating self-injectable calcitonin gene-related peptide monoclonal antibody and novel acute medication
  • Patterns of Prescription Nonsteroidal Anti-Inflammatory Drug (NSAID) Use Among Osteoarthritis Patients in the United States: Real World Evidence
  • Patterns of viral arthropathy / myalgia with the SARS-CoV-2 epidemic
  • Personalized Pain Therapy: An Artificial Intelligence (AI) Method and Web-Tool to Predict Patient Response to OTC Topical Analgesics
  • Pooled Analysis of the Efficacy of Fremanezumab for Reducing Disability and Acute Medication Overuse in Migraine Patients Overusing Migraine-specific Acute Medications at Baseline
  • Presumptive Versus Definitive Drug Testing: What Are We Missing
  • Primary Headache Disorders and Acute Medications Associated With Patients Diagnosed With Medication Overuse Headache: Analysis of US Claims Data
  • Process of the application of Qutenza (Capsaicin 8%) topical patches for diabetic neuropathy
  • Prolotherapy: A Palliative Therapy for Hypermobile Ehlers-Danlos Syndrome
  • Proof of Concept Study Evaluating the Relative Efficacy and Safety of Concomitant Acetaminophen-Naproxen Sodium versus Acetaminophen/Hydrocodone and Naproxen in Postoperative Dental Pain
  • Proposed Risk Stratification of Drug Effect on Inducing Respiratory Depression
  • Prospective, Multicenter Study of Percutaneous Medial Branch PNS for the Treatment of Chronic Axial Low Back Pain
  • Racial variations in healthcare resource use and expenditures in a population of Medicaid patients with knee/hip osteoarthritis
  • Real World Evidence Data from UK to support Treatment with Capsaicin 8% Topical System in Various Peripheral Neuropathic Pain Conditions.
  • Real World Evidence of Sustained Improvements Following Percutaneous PNS: A Retrospective Cross-Sectional Follow-Up Survey of 354 Patients
  • Reasons for Hesitating to Consult for Migraine Care: Results of the OVERCOME (US) Study
  • Repeat Dosing With Subcutaneous Methylnaltrexone: A Pooled Analysis in Patients With and Without Cancer
  • Retrospective Analysis of High concentration Capsaicin Topical System for the treatment of post amputation stump pain and phantom limb pain
  • Retrospective comparison of the effectiveness of buprenorphine versus baclofen for acute opiate withdrawal
  • Risk Stratification of Respiratory Depression With Buprenorphine Buccal Film Versus Oxycodone: Outcomes From a Phase 1 Placebo-Controlled Trial
  • SC Methylnaltrexone in Patients with Advanced Illness and OIC: The Impact of Baseline Laxative Use
  • Skeletal Muscle Spasms and Pain and Dysfunction
  • Suicide by Opioid
  • Sustained Benefits of 10 kHz Spinal Cord Stimulation for Painful Diabetic Neuropathy - 6-Month Randomized Controlled Trial Results
  • Symptoms and diagnosis of painful diabetic peripheral neuropathy: the patient’s experience
  • Termination of effect of long acting injectable naltrexone and related challenges
  • The Association between Opioid Use Disorder and Childhood Adverse Experiences
  • The Body Function, Activity Limitations, and Participation Restrictions of Individuals with Poly-Trauma Clinical Triad
  • The Disparate Definitions and Measures of Post-Operative Respiratory Depression
  • The effectiveness of an Audio-Visual-Stimulation device in managing Fibromyalgia
  • The effectiveness of thermal neuromodulation using precise heat in the treatment of chronic low back pain over 60 days. An in-home user trial.
  • The polysubstance overdose-death crisis
  • The problem of postoperative respiratory depression
  • The use of acupuncture to facilitate goal-setting in chronic pain management
  • Total Pain Burden in Patients With Treatment-resistant Migraine: Effects of Galcanezumab in the CONQUER Phase 3b Trial
  • Treatment of painful diabetic peripheral neuropathy: the patient’s experience
  • Ubrogepant Treatment When Pain Is Mild Increases the Likelihood of Achieving Pain Freedom in Participants Who Treated Migraine Attacks of Mild and Moderate or Severe Pain
  • Ubrogepant Was Safe and Well Tolerated in the Acute Treatment of Perimenstrual Migraine Attacks
  • Ultrasound-Guided Dorsal Penile Blocks as an Effective Form of Analgesia for Circumcision
  • Update on In Vivo Testing of NTM-006 (formerly JNJ-10450232), a Novel Orally-Active Non-Opioid Analgesic: CFA and Paw Edema
  • Update on In Vivo Testing of NTM-006 (formerly JNJ-10450232), a Novel Orally-Active Non-Opioid Analgesic: Neuropathic Pain Model
  • What Patients Report Being Discussed During Their Most Recent Visit for Headache in Primary Care: Association with Being Diagnosed with Migraine